Showing 481 - 500 results of 71,316 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 0.74s Refine Results
  1. 481
  2. 482
  3. 483
  4. 484
  5. 485

    <i>Oenocarpus bacaba</i> palm tree (A) and fruit (B). by Eudes Alves Simões-Neto (19697968)

    Published 2024
    “…Diagnosis criteria included positive peripheral blood smear (PBS), seroconversion of IgG, and a two-fold increase in IgG titer (laboratory criteria); and clinical findings, epidemiological exposure, and at least one positive IgG test (clinical-epidemiological criteria). …”
  6. 486

    Evolved <i>efgA</i> alleles have a variety of predicted folding and binding stabilities. by Jannell V. Bazurto (7847171)

    Published 2021
    “…<p>We used our MD+FoldX approach [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001208#pbio.3001208.ref079" target="_blank">79</a>] to predict the effect of all possible 19 mutations at each amino acid site on monomers or tetramer formation. …”
  7. 487
  8. 488
  9. 489
  10. 490
  11. 491
  12. 492

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. Interestingly, <b>4f</b> showed remarkable PI3K/AKT/mTOR inhibitory activity with 0.18-, 0.27-, and 0.39-fold decrease in their concentration (reduction in controls from 6.64, 45.39, and 86.39 ng/mL to 1.24, 12.35, and 34.36 ng/mL, respectively). …”
  13. 493

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. Interestingly, <b>4f</b> showed remarkable PI3K/AKT/mTOR inhibitory activity with 0.18-, 0.27-, and 0.39-fold decrease in their concentration (reduction in controls from 6.64, 45.39, and 86.39 ng/mL to 1.24, 12.35, and 34.36 ng/mL, respectively). …”
  14. 494
  15. 495
  16. 496
  17. 497
  18. 498
  19. 499

    The primer information. by Guangxiao Ni (19713106)

    Published 2024
    “…MiR-199a-5p decreased the expression of PIK3R2 after MCAO, activated Akt signaling pathway, and increased the expression of Claudin-5 and VEGF in the ischemic penumbra. …”
  20. 500

    Evans Blue extravasation between groups. by Guangxiao Ni (19713106)

    Published 2024
    “…MiR-199a-5p decreased the expression of PIK3R2 after MCAO, activated Akt signaling pathway, and increased the expression of Claudin-5 and VEGF in the ischemic penumbra. …”